Trademark Search in Canada

TEKTURNA & DESIGN

View On IC.GC.CA

REGISTERED

on 8 Jul 2019

Last Applicant/ Owned by

NODEN PHARMA DAC

D' Olier Chambers16A D' Olier StreetDublin 2

Serial Number

1805820 filed on 21^st Oct 2016

Registration Number

TMA1037490 registered on 8^th Jul 2019

Registration expiry Date

8^th Jul 2029

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

K1P5Y6

TEKTURNA & DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous Read More

Vienna Information

1 . 1 . 15

Comets, stars with tailComètes, étoiles avec queue

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 5

More than two circles or ellipses, inside one another, spiralsPlus de deux cercles ou ellipses, les uns dans les autres, spirales

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases including metabolic disorders and diabetes; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; immunosuppressants; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; control solutions and control reagents for use on medical and diagnostic devices for accuracy control of test results; control solutions and control reagents for the calibration and for monitoring the function of medical and diagnostic devices; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; in vitro diagnostic agents for medical use; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma or damage to the tissue or skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication

Classification kind code

Mark Details

Serial Number

1805820

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 6^th Jul 2018	Allowed
Submitted for opposition 42 on 21^st Mar 2018	Advertised
Submitted for opposition 26 on 1^st Mar 2018	Approved
Submitted for opposition 27 on 9^th Jan 2018	Approval Notice Sent
Submitted for opposition 22 on 14^th Sept 2017	Search Recorded
Submitted for opposition 20 on 14^th Sept 2017	Examiner's First Report
Submitted for opposition 135 on 27^th Feb 2017	Amendment to Application
Submitted for opposition 31 on 25^th Oct 2016	Formalized
Submitted for opposition 1 on 24^th Oct 2016	Created
Submitted for opposition 30 on 21^st Oct 2016	Filed